Next Article in Journal
An Assessment of the Molecular Diversity of Ticks and Tick-Borne Microorganisms of Small Ruminants in Pakistan
Previous Article in Journal
Correction: Saarinen, N.V.V., et al. Multiplexed High-Throughput Serological Assay for Human Enteroviruses. Microorganismis 2020, 8, 963
Open AccessArticle

A Protective Vaccine against Johne’s Disease in Cattle

1
Pan Genome Systems, Madison, WI 53719, USA
2
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA
3
Research Animal Resources Center, University of Wisconsin-Madison, Madison, WI 53706, USA
4
Department of Materials Design and Innovation, University at Buffalo, State University of New York, New York, NY 14260, USA
*
Author to whom correspondence should be addressed.
Microorganisms 2020, 8(9), 1427; https://doi.org/10.3390/microorganisms8091427
Received: 3 August 2020 / Revised: 12 September 2020 / Accepted: 15 September 2020 / Published: 17 September 2020
(This article belongs to the Section Antimicrobial Agents and Resistance)
Johne’s disease (JD) caused by Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis) is a chronic infection characterized by the development of granulomatous enteritis in wild and domesticated ruminants. It is one of the most significant livestock diseases not only in the USA but also globally, accounting for USD 200–500 million losses annually for the USA alone with potential link to cases of Crohn’s disease in humans. Developing safe and protective vaccines is of a paramount importance for JD control in dairy cows. The current study evaluated the safety, immunity and protective efficacy of a novel live attenuated vaccine (LAV) candidate with and without an adjuvant in comparison to an inactivated vaccine. Results indicated that the LAV, irrespective of the adjuvant presence, induced robust T cell immune responses indicated by proinflammatory cytokine production such as IFN-γ, IFN-α, TNF-α and IL-17 as well as strong response to intradermal skin test against M. paratuberculosis antigens. Furthermore, the LAV was safe with minimal tissue pathology. Finally, calves vaccinated with adjuvanted LAV did not shed M. paratuberculosis post-challenge, a much-desired characteristic of an effective vaccine against JD. Together, this data suggests a strong potential of testing LAV in field trials to curb JD in dairy herds. View Full-Text
Keywords: live attenuated vaccine; Mycobacterium avium subsp. paratuberculosis; Johne’s disease; bovine vaccine live attenuated vaccine; Mycobacterium avium subsp. paratuberculosis; Johne’s disease; bovine vaccine
Show Figures

Figure 1

MDPI and ACS Style

Phanse, Y.; Wu, C.-W.; Venturino, A.J.; Hansen, C.; Nelson, K.; Broderick, S.R.; Steinberg, H.; Talaat, A.M. A Protective Vaccine against Johne’s Disease in Cattle. Microorganisms 2020, 8, 1427.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop